Enhanced recovery after surgery pathways benefit patients with soft pancreatic texture following pancreaticoduodenectomy - 08/06/20
Abstract |
Background |
We aimed to compare the enhanced recovery after surgery pathway with the standard perioperative care protocol concerning complications, postoperative length of stay and 1-year survival rate.
Methods |
Using a before–after cohort study design, data from patients with pancreatic head cancer, who consecutively underwent pancreaticoduodenectomy, were retrospectively collected.
Results |
Compared to the control group, patients with soft pancreas in the enhanced recovery after surgery group had a lower incidence of delayed gastric emptying (36.7% vs 13.3%, P = 0.026) and respiratory complications (46.7% vs 20.0%, P = 0.028), and shorter postoperative length of stay (All: 10.9 ± 3.4 d vs13.5 ± 3.8 d, P = 0.002; Soft: 11.2 ± 3.8 d vs14.0 ± 4.5 d, P = 0.001). The 1-year survival rates were similar between the groups.
Conclusion |
The enhanced recovery after surgery pathways can significantly reduce the incidence of certain surgical complications and decrease the postoperative length of stay. It does not affect 1-year survival.
Le texte complet de cet article est disponible en PDF.Highlights |
• | ERAS can significantly reduce the incidence of certain surgical complications. |
• | ERAS can decrease the postoperative length of stay. |
• | ERAS does not affect 1-year survival. |
Keywords : Clinical pathways, Pancreatic cancer, Pancreaticoduodenectomy, Postoperative complications, Soft pancreatic texture
Plan
Vol 219 - N° 6
P. 1019-1023 - juin 2020 Retour au numéro
Article précédent
- Disparities influencing rates of urgent/emergent surgery for diverticulitis in the state of Florida
- Riccardo Lemini, Aaron C. Spaulding, Osayande Osagiede, Jordan J. Cochuyt, James M. Naessens, Marie Crandall, Robert R. Cima, Dorin T. Colibaseanu
- Volumetric histogram analysis of apparent diffusion coefficient for predicting pathological complete response and survival in esophageal cancer patients treated with chemoradiotherapy
- Atsushi Hirata, Koichi Hayano, Gaku Ohira, Shunsuke Imanishi, Toshiharu Hanaoka, Kentaro Murakami, Tomoyoshi Aoyagi, Kiyohiko Shuto, Hisahiro Matsubara
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?